Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)

NCT05164055 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Glycogen Storage Disease Type II

Interventions

DRUG: Avalglucosidase alfa (GZ402666)

Sponsor

Genzyme, a Sanofi Company